Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Arrowhead Research Corporation President & CEO to Attend Roth Capital Partners Conference

Abstract:
Arrowhead (NASDAQ: ARWR) ("Arrowhead") President and Chief Executive Officer Dr. Christopher Anzalone will be in attendance at the 21st Annual Roth Capital Partners OC Growth Stock Conference in Dana Point, California on Tuesday, February 17, 2009 and will be available to meet with members of the investment community. Arrowhead is a nanotechnology company that is commercializing new technologies in the areas of life sciences, electronics, and energy. As owners of key nanotechnology assets in these markets, Arrowhead and its subsidiaries are well-positioned to capitalize on a significant market opportunity. Key partners and customers include Samsung Electronics, Tokyo Electron, Entegris, Inc. and The Battelle Memorial Institute.

Arrowhead Research Corporation President & CEO to Attend Roth Capital Partners Conference

PASADENA, CA | Posted on February 12th, 2009

To arrange a meeting with Dr. Anzalone at the Growth Stock Conference, please contact: Virginia Dadey; Vice President, Investor Relations Telephone: 212.541.3707 Email:

Arrowhead is building value for shareholders through the progress of majority owned subsidiaries founded on nanotechnologies originally developed at universities. The Company works closely with universities to source early stage deals and to generate rights to intellectual property covering promising new nanotechnologies. Arrowhead currently has two wholly owned subsidiaries (the "Subsidiaries"), two majority-owned subsidiaries and has minority investments in two development stage nanotechnology companies. The Company's Subsidiaries seek to commercialize a variety of nanotech products and applications, including anti-cancer drugs, RNAi therapeutics, carbon-based electronics and fullerene antioxidants. The Company's minority investments are focused on developing advanced nanomaterials for spinal cord injury and wound healing and drug delivery technology.

Arrowhead's most recent financial results can be found here: www.arrowres.com/publications/090209040951.html. An archived webcast of its financial announcement conference call can be accessed here: phx.corporate-ir.net/playerlink.zhtml?c=120497&s=wm&e=2084013. Visit Arrowhead's home page for additional information: www.arrowheadresearch.com. Arrowhead at a Glance: Recent Price (2/11/09): $0.73 Shares outstanding: 42.9M Market capitalization: $31.3M Fiscal Year End: September 30

####

About Arrowhead Research Corporation
Arrowhead Research Corporation (www.arrowheadresearch.com) is a publicly-traded nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy. Arrowhead is building value for shareholders through the progress of majority owned subsidiaries founded on nanotechnologies originally developed at universities. The company works closely with universities to source early stage deals and to generate rights to intellectual property covering promising new nanotechnologies. Currently, Arrowhead has four subsidiaries commercializing nanotech products and applications, including anti-cancer drugs, RNAi therapeutics, carbon-based electronics and compound semiconductor materials.

For more information, please click here

Contacts:

Copyright © Arrowhead Research Corporation

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

University of Minnesota engineers make sound loud enough to bend light on a computer chip: Device could improve wireless communications systems November 28th, 2014

Study details laser pulse effects on behavior of electrons November 28th, 2014

Single-atom gold catalysts may offer path to low-cost production of fuel and chemicals November 28th, 2014

Production of Anticancer Drug from Nanofibers in Iran November 28th, 2014

Investments/IPO's/Splits

Nanometrics Announces Upcoming Investor Events November 19th, 2014

Eight19 secures 1m funding: Investment to develop production technology, and expand commercial activities for organic photovoltaics November 19th, 2014

Arrowhead to Present at Upcoming Conferences November 15th, 2014

Harris & Harris Group Reports Financial Statements as of September 30, 2014 November 11th, 2014

Announcements

University of Minnesota engineers make sound loud enough to bend light on a computer chip: Device could improve wireless communications systems November 28th, 2014

Study details laser pulse effects on behavior of electrons November 28th, 2014

Single-atom gold catalysts may offer path to low-cost production of fuel and chemicals November 28th, 2014

Production of Anticancer Drug from Nanofibers in Iran November 28th, 2014

Events/Classes

SEMATECH to Showcase Innovation and Advances in Manufacturing at SEMICON Japan 2014: SEMATECH experts will share the latest techniques, emerging trends and best practices in advanced manufacturing strategies and methodologies November 26th, 2014

Professional AFM Images with a Three Step Click SmartScan by Park Systems Revolutionizes Atomic Force Microscopy by Automatizing the Imaging Process November 24th, 2014

3rd Iran-Proposed Nano Standard Approved by International Standard Organization November 22nd, 2014

Sustainable Nanotechnologies Project November 20th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More












ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE